|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the Quarterly period ended March 31, 2005 | ||
| OR | ||
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OR THE SECURITIES EXCHANGE ACT 1934 | |
| For the transition period from to | ||
|
California
|
77-0270079 | |
|
(State or other jurisdiction of incorporation) |
(I.R.S. Employer Identification No.) |
| Title of Each Class | Outstanding at March 31, 2005 | |
| Common Stock, no par value | 63,955,194 Shares |
2
| ITEM 1. | FINANCIAL STATEMENTS |
| March 31, | December 31, | |||||||||
| 2005 | 2004 | |||||||||
| (Unaudited) | As restated(1) | |||||||||
| (In thousands) | ||||||||||
| ASSETS | ||||||||||
|
Current Assets:
|
||||||||||
|
Cash and cash equivalents
|
$ | 30,876 | $ | 23,446 | ||||||
|
Short-term investments
|
190,770 | 229,226 | ||||||||
|
Accounts receivable, net
|
19,011 | 14,204 | ||||||||
|
Inventories
|
2,504 | 2,191 | ||||||||
|
Prepaid expenses and other current assets
|
3,712 | 2,069 | ||||||||
|
Total current assets
|
246,873 | 271,136 | ||||||||
|
Property and equipment, net
|
2,890 | 3,395 | ||||||||
|
Goodwill
|
97,953 | 97,953 | ||||||||
|
Purchased intangibles and other assets, net
|
12,421 | 14,361 | ||||||||
| $ | 360,137 | $ | 386,845 | |||||||
| LIABILITIES AND SHAREHOLDERS EQUITY | ||||||||||
|
Current Liabilities:
|
||||||||||
|
Accounts payable
|
$ | 6,499 | $ | 5,737 | ||||||
|
Accrued payroll and related benefits
|
6,470 | 7,342 | ||||||||
|
Other accrued liabilities
|
3,971 | 5,117 | ||||||||
|
Deferred revenue
|
32,453 | 30,173 | ||||||||
|
Income taxes payable
|
525 | 500 | ||||||||
|
Total current liabilities
|
49,918 | 48,869 | ||||||||
|
Commitments and contingencies (see Note 9)
|
||||||||||
|
Shareholders Equity:
|
||||||||||
|
Common stock
|
434,934 | 463,733 | ||||||||
|
Accumulated other comprehensive loss
|
(1,478 | ) | (846 | ) | ||||||
|
Accumulated deficit
|
(123,237 | ) | (124,911 | ) | ||||||
|
Total shareholders equity
|
310,219 | 337,976 | ||||||||
| $ | 360,137 | $ | 386,845 | |||||||
| (1) | Amounts as of December 31, 2004 have been derived from the audited financial statements as of the same date. |
3
| Three Months Ended | ||||||||||
| March 31, | ||||||||||
| 2005 | 2004 | |||||||||
| As restated | ||||||||||
| (In thousands, except | ||||||||||
| per share data) | ||||||||||
| (Unaudited) | ||||||||||
|
Revenue:
|
||||||||||
|
Product
|
$ | 18,197 | $ | 22,718 | ||||||
|
License and service
|
13,608 | 9,117 | ||||||||
|
Total revenue
|
31,805 | 31,835 | ||||||||
|
Cost of revenue:
|
||||||||||
|
Product
|
6,447 | 8,139 | ||||||||
|
License and service
|
1,978 | 1,515 | ||||||||
|
Amortization of purchased technology
|
1,136 | 1,136 | ||||||||
|
Total cost of revenue
|
9,561 | 10,790 | ||||||||
|
Gross margin
|
22,244 | 21,045 | ||||||||
|
Operating expenses:
|
||||||||||
|
Research and development, excluding amortization
(recovery) of stock-based compensation of $(75) and $147,
respectively
|
5,456 | 5,980 | ||||||||
|
Sales and marketing
|
12,171 | 11,402 | ||||||||
|
General and administrative
|
3,550 | 3,790 | ||||||||
|
Amortization of purchased intangibles
|
703 | 812 | ||||||||
|
Restructuring charges
|
| 13 | ||||||||
|
Amortization of stock-based compensation
|
(75 | ) | 147 | |||||||
|
Total operating expenses
|
21,805 | 22,144 | ||||||||
|
Income (loss) from operations
|
439 | (1,099 | ) | |||||||
|
Interest income and other expense, net
|
1,356 | 835 | ||||||||
|
Income (loss) before income taxes
|
1,795 | (264 | ) | |||||||
|
Provision for income taxes
|
(121 | ) | (85 | ) | ||||||
|
Net income (loss)
|
$ | 1,674 | $ | (349 | ) | |||||
|
Net income (loss) per share:
|
||||||||||
|
Basic
|
$ | 0.03 | $ | (0.00 | ) | |||||
|
Diluted
|
$ | 0.02 | $ | (0.00 | ) | |||||
|
Shares used in computing net loss per share:
|
||||||||||
|
Basic
|
65,713 | 70,051 | ||||||||
|
Diluted
|
67,998 | 70,051 | ||||||||
4
| Three Months Ended | ||||||||||||
| March 31, | ||||||||||||
| 2005 | 2004 | |||||||||||
| As restated | ||||||||||||
| (In thousands) | ||||||||||||
| (Unaudited) | ||||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net income (loss)
|
$ | 1,674 | $ | (349 | ) | |||||||
|
Adjustments to reconcile net income (net loss) to net cash
provided by (used in) operating activities:
|
||||||||||||
|
Depreciation and amortization
|
2,517 | 2,868 | ||||||||||
|
Reduction in allowance of doubtful accounts and other
|
81 | (91 | ) | |||||||||
|
Amortization (reversal) of stock-based compensation
|
(75 | ) | 147 | |||||||||
|
Non-cash restructuring charges
|
| 13 | ||||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||
|
Accounts receivable
|
(4,807 | ) | (3,339 | ) | ||||||||
|
Inventories
|
(313 | ) | (907 | ) | ||||||||
|
Prepaid expenses and other current assets
|
(1,643 | ) | (353 | ) | ||||||||
|
Other assets
|
101 | (52 | ) | |||||||||
|
Accounts payable
|
762 | (961 | ) | |||||||||
|
Accrued payroll and related benefits
|
(872 | ) | 1,877 | |||||||||
|
Other accrued liabilities
|
(1,146 | ) | 123 | |||||||||
|
Deferred revenue
|
2,280 | 2,499 | ||||||||||
|
Income taxes payable
|
25 | (51 | ) | |||||||||
|
Net cash provided by (used in) operating activities
|
(1,416 | ) | 1,424 | |||||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Purchase of property and equipment
|
(177 | ) | (640 | ) | ||||||||
|
Maturity and sale of short-term investments
|
60,846 | 59,552 | ||||||||||
|
Purchase of short-term investments
|
(23,100 | ) | (30,691 | ) | ||||||||
|
Net cash provided by investing activities
|
37,569 | 28,221 | ||||||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Issuance of common stock under employee stock options and
purchase plans
|
1,205 | 10,718 | ||||||||||
|
Repurchase of common stock
|
(29,928 | ) | | |||||||||
|
Net cash provided by (used in) financing activities
|
(28,723 | ) | 10,718 | |||||||||
|
Net increase in cash and cash equivalents
|
7,430 | 40,363 | ||||||||||
|
Cash and cash equivalents at beginning of period
|
23,446 | 30,467 | ||||||||||
|
Cash and cash equivalents at end of period
|
$ | 30,876 | $ | 70,830 | ||||||||
|
Supplemental disclosure of non-cash investing and financing
activities:
|
||||||||||||
|
Unrealized loss on short-term investments, net of taxes
|
$ | (632 | ) | $ | 19 | |||||||
5
| 1. | CONSOLIDATED FINANCIAL STATEMENTS |
| 2. | RESTATEMENT |
| Three Months Ended March 31, 2004 | |||||||||||||
| As | |||||||||||||
| Previously | |||||||||||||
| Reported | Adjustments | As Restated | |||||||||||
| (In thousands, except per share amounts) | |||||||||||||
|
Revenue
|
|||||||||||||
|
Product
|
$ | 22,718 | $ | | $ | 22,718 | |||||||
|
License and service
|
9,117 | | 9,117 | ||||||||||
|
Total revenue
|
31,835 | | 31,835 | ||||||||||
|
Cost of revenue
|
|||||||||||||
|
Product
|
8,120 | 19 | 8,139 | ||||||||||
|
License and service
|
1,505 | 10 | 1,515 | ||||||||||
|
Amortization of purchased technology
|
1,136 | | 1,136 | ||||||||||
|
Total cost of revenue
|
10,761 | 29 | 10,790 | ||||||||||
|
Gross Margin
|
21,074 | (29 | ) | 21,045 | |||||||||
|
Operating expenses:
|
|||||||||||||
|
Research and development
|
5,990 | (10 | ) | 5,980 | |||||||||
|
Sales and marketing
|
11,258 | 144 | 11,402 | ||||||||||
|
General and administrative
|
3,749 | 41 | 3,790 | ||||||||||
6
| Three Months Ended March 31, 2004 | |||||||||||||
| As | |||||||||||||
| Previously | |||||||||||||
| Reported | Adjustments | As Restated | |||||||||||
| (In thousands, except per share amounts) | |||||||||||||
|
Amortization purchased intangibles
|
812 | | 812 | ||||||||||
|
Restructuring charges
|
13 | | 13 | ||||||||||
|
Stock-based compensation
|
147 | | 147 | ||||||||||
|
Total operating expenses
|
21,969 | 175 | 22,144 | ||||||||||
|
Loss from operations
|
(895 | ) | (204 | ) | (1,099 | ) | |||||||
|
Interest income and other expenses, net
|
835 | | 835 | ||||||||||
|
Loss before income taxes
|
(60 | ) | (204 | ) | (264 | ) | |||||||
|
Provision for income taxes
|
(99 | ) | 14 | (85 | ) | ||||||||
|
Net loss
|
$ | (159 | ) | (190 | ) | $ | (349 | ) | |||||
|
Basic and diluted net loss per share
|
$ | 0.00 | $ | (0.01 | ) | $ | (0.00 | ) | |||||
| December 31, 2004 | ||||||||||||
| As | ||||||||||||
| Previously | ||||||||||||
| Reported | Adjustments | As Restated | ||||||||||
| (In thousands) | ||||||||||||
|
Accrued payroll and related benefits
|
$ | 8,409 | $ | (1,067 | ) | $ | 7,342 | |||||
|
Total current liabilities
|
49,936 | (1,067 | ) | 48,869 | ||||||||
|
Accumulated deficit
|
(125,906 | ) | 995 | (124,911 | ) | |||||||
|
Total shareholders equity
|
336,909 | 1,067 | 337,976 | |||||||||
| 3. | CONSOLIDATION |
7
| 4. | NET INCOME (LOSS) PER SHARE |
| Three Months Ended | ||||||||||
| March 31, | ||||||||||
| 2005 | 2004 | |||||||||
| As restated | ||||||||||
|
Numerator:
|
||||||||||
|
Net income (loss)
|
$ | 1,674 | $ | (349 | ) | |||||
|
Denominator:
|
||||||||||
|
Weighted average shares used to compute basic EPS
|
65,713 | 70,051 | ||||||||
|
Effect of dilutive securities:
|
||||||||||
|
Dilutive common stock equivalents
|
2,230 | | ||||||||
|
Dilutive common stock warrants
|
55 | | ||||||||
|
Weighted average shares used to compute diluted EPS
|
67,998 | 70,051 | ||||||||
|
Net income (loss) per share:
|
||||||||||
|
Basic
|
$ | 0.03 | $ | (0.00 | ) | |||||
|
Diluted
|
$ | 0.02 | $ | (0.00 | ) | |||||
| 5. | COMPREHENSIVE INCOME (LOSS) |
|   |